Setting the stage for cancer startups.
Early-stage investors give their views on today's volatile environment for oncology startups.
D000970:Antineoplastic Agents; D035843:Biomedical Research; D001709:Biotechnology; D003362:Cost-Benefit Analysis; D055808:Drug Discovery; D004345:Drug Industry; D006801:Humans; D007449:Investments
D000970:Antineoplastic Agents